Study: Traditional prostate cancer risks don’t predict hormone therapy benefit
A large analysis led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has challenged a widely used assumption...
Rowan Blackwood covers cancer and oncology, including tumor biology, screening, diagnostics, treatment research, clinical trials, and survivorship science.
A large analysis led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has challenged a widely used assumption...
CAMBRIDGE, Massachusetts—Researchers from the University of Copenhagen, Insilico Medicine, and international academic partners have identified a previously unrecognized vulnerability in...
Ewing sarcoma, an aggressive cancer that predominantly affects children and adolescents, has long challenged researchers because of its ability to...
The University of Chicago Medicine Comprehensive Cancer Center and Eli Lilly and Company have launched a two-year partnership aimed at...
A mathematical model developed by researchers at The University of Texas at Arlington may help resolve one of melanoma treatment’s...
A previously underexplored population of immune cells in the bone marrow may help explain why some patients with multiple myeloma...
A new randomized phase 3 study suggests that genetic risk profiling could help determine which patients with advanced epidermal growth...
PITTSBURGH, August 10, 2026 — Women living in socially vulnerable communities face a significantly higher risk of dying after an...
Gastric cancer may be exploiting a little-known metabolic molecule to disable the immune system, according to research from Keio University...
Triple-negative breast cancer has long presented one of oncology’s most difficult challenges: it lacks the three molecular markers—estrogen receptor, progesterone...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine